A Louisiana federal judge has reduced the $9 billion punitive damages award against Takeda Pharmaceutical Co. Ltd. and Eli Lilly & Co. over the diabetes drug Actos to $36.8 million. U.S.... Read more
U.S. District Judge Rebecca Doherty has rejected the attempt by Takeda Pharmaceutical Co. and Eli Lilly & Co. to get the combined $9 billion punitive-damage award returned by a jury thro... Read more
Blue Cross and Blue Shield of Massachusetts Inc. has filed a number of subrogation actions in the Louisiana multidistrict litigation (MDL) over the bladder cancer risks carried by Takeda Pha... Read more
A federal jury in Lafayette, La., last month ordered Takeda Pharmaceutical Co., based in Osaka, Japan, and its partner, Eli Lilly & Co, based in Indianapolis, Ind., to pay a combined $9... Read more
Eli Lilly and Co., the Indianapolis drug maker, will settle an investigation by federal and state authorities over the antipsychotic Zyprexa. The government’s investigation is related... Read more
Eli Lilly & Co. will pay $62 million to resolve claims relating to the marketing and promotion of its anti-psychotic drug Zyprexa to patients who did not have schizophrenia or bipolar d... Read more
A federal judge in Brooklyn, New York, ruled recently that pension funds, labor unions and insurance companies that bought Eli Lilly & Co’s Zyprexa drug could sue as a group and w... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.